Rep. Charlie Crist

Preserving Accountability for National Assets Act of 2021 or the PANA Act This bill establishes the Venezuela Restoration Fund to strengthen democratic governance and institutions, defend human rights, support independent media outlets, and combat corruption and improve transparency in Venezuela. Any funds or assets forfeited to the United States by an individual or entity connected to the regimes of Hugo Chávez and Nicolás Maduro in Venezuela will be deposited into this fund.

This resolution expresses support for the goals and ideals of PCOS Awareness Month. Polycystic ovary syndrome (PCOS) is caused by a hormone imbalance. Symptoms can include infertility, weight gain, excess hair growth, and acne.

Student Loan Rehabilitation and Credit Score Improvement Act of 2022 This bill provides for the removal of any adverse credit history related to a federal student loan from a borrower's credit history once the borrower has completed loan rehabilitation.

Senior Guardianship Social Security Protection Act of 2022 This bill requires the Social Security Administration (SSA) to establish agreements with each state to share certain information on a monthly basis about the guardianship arrangements of individuals who are entitled to Social Security benefits or Supplemental Security Income (a federal assistance program that provides monthly cash payments to aged, blind, or disabled individuals with limited income and resources). The SSA must also periodically report to Congress about Social Security payments that are diverted to nonfamilial representative payees (i.e., individuals appointed by the SSA to manage payments on behalf of recipients).

Tiny Homes for Homeless Veterans Act This bill requires the Department of Veterans Affairs to implement a six-year pilot program to provide grants for the creation of five villages of tiny homes for homeless veterans. Under the bill, the villages must have associated supportive services to allow veterans to build and live in energy efficient homes, maintain social connections with each other, learn skills, and receive critical counseling. Under the bill, a tiny home is an individual housing unit that is approximately 240 square feet for one person or approximately 340 square feet if the home is for a family.

PrEP Access and Coverage Act This bill requires private health insurance plans to cover prescription drugs that prevent HIV, including related screenings, diagnostic procedures, administrative fees, and clinical follow-ups, without any cost-sharing obligation for the plan holder. Further, insurance plans must not impose any preauthorization requirement for this coverage. These coverage requirements also apply to public health insurance programs, including Medicare, Medicaid, and the Children's Health Insurance Program. Additionally, the bill prohibits denying, limiting, or qualifying coverage or increasing premiums for disability insurance, long-term care insurance, or life insurance policies based on an individual taking medication for HIV prevention. The bill further requires the Department of Health and Human Services to award grants to states, or directly to eligible local organizations, to provide uninsured individuals and underinsured individuals access to prescription drugs and related services that prevent HIV. The Centers for Disease Control and Prevention also must develop a public awareness campaign that focuses efforts in communities with a high need for HIV prevention treatment.

College Student Hunger Act of 20 21 This bill modifies the eligibility requirements for the Supplemental Nutrition Assistance Program (SNAP) to make additional students at institutions of higher education eligible for benefits.

Accelerating Access to Critical Therapies for ALS Act This bill establishes grant programs to address neurodegenerative diseases, such as amyotrophic lateral sclerosis (also known as ALS or Lou Gehrig's disease), and contains other related provisions. The Department of Health and Human Services (HHS) shall award grants to eligible entities for scientific research utilizing data from expanded access to investigational ALS treatments for individuals who are not otherwise eligible for clinical trials.  The Food and Drug Administration (FDA) shall award grants to public and private entities to cover the costs of research and development of drugs that diagnose or treat ALS and other rare neurodegenerative diseases. HHS shall also establish the Public-Private Partnership for Neurodegenerative Diseases between the National Institutes of Health, the FDA, and at least one eligible entity (generally, an institution of higher education or a nonprofit organization). The partnership shall support the development and regulatory review of drugs that address ALS and other rare neurodegenerative diseases. The FDA shall publish on its website a five-year action plan for fostering the development of drugs that improve or extend the lives of people living with rare neurodegenerative diseases. The Government Accountability Office must report to Congress about the grants provided under this bill, including an analysis of the impact of such grants on research and development of treatments for ALS.

This bill posthumously provides for the award of a Congressional Gold Medal in commemoration of the 13 service members who died on August 26, 2021, while stationed at Hamid Karzai International Airport in Afghanistan.

Humane Cosmetics Act of 2021 This bill generally prohibits animal testing in the evaluation of cosmetic products, and it prohibits the sale or transport of cosmetics developed using animal testing, subject to civil penalties. These prohibitions begin one year after enactment. The bill specifies exceptions to these prohibitions, including if such animal testing (1) is conducted outside the United States to comply with a foreign regulatory authority; (2) is pursuant to a specified finding that there are no nonanimal alternatives to test the safety of a potentially dangerous cosmetic product or ingredient; (3) is of a product or ingredient for a drug or device subject to regulation by the Food and Drug Administration (FDA); or (4) is required for a noncosmetic purpose pursuant to a state, federal, or foreign regulatory authority. Further, no animal-testing evidence may be used to establish the safety of a cosmetic product or ingredient that is regulated by the FDA after the effective date of this bill, subject to limited exceptions.